NovoCure Ltd (NVCR) 옵션

A very bad day for $NVCR but all is not lost! I'm transferring all shares to ten of my favorite charities all are still in the money don't you know. Wishing everyone much peace, happiness! GLTA

KEYNOTE-D58 is a pivotal trial (N=741) of Optune concomitant with temozolomide plus keytruda in ndGBM. The estimated primary completion date is April 2029.

Data from the PhII 2-THE-TOP trial https://www.onclive.com/view/temozolomide-pembrolizumab-plus-ttfields-leads-to-tumor-control-in-newly-diagnosed-glioblastoma

dennisbabe - You are not smart enough to be impactful one way or another..
You are just one irrelevant poster.....

LOL - Garbage post....

thank you very much for sharing jondoeuk!

It is a pilot trial, but mPDAC is the largest category at diagnosis. Depending on the data (and if a pivotal trial ends up being successful), TTFs could eventually be used across all diagnosis categories.

Wishing a Happy New Year to everyone who is invested in $NVCR!

dennisdave, you & FeMike are made for each other. The two Irrelevant Scam Artistwannabies, begging for attention..

You are both piles of SSSSSSSSSSSSS.......HIT....

And you jondickuk, crawling around to save your clients from bad advise you capable of giving..

LOL....

$NVCR has reached its 52-week high! Wishing everyone a great weekend! GLTA

Thank you for sharing!
They seem to believe this makes it to market in CRC is my read.

A phase 2 trial, PANOVA-4, will test TTFields combined with a triplet regimen of gemcitabine, nab-paclitaxel and atezolizumab as a first-line treatment for metastatic pancreatic ductal adenocarcinoma. It has completed enrolment and the company said it expects to have data in 2026.

The primary endpoint is disease control rate (DCR). Secondary endpoints include, overall survival (OS), progression-free survival (PFS), 1-year OS rate, objective response rate (ORR), PFS at 6 months, duration of response, and safety.

$NVCR what a great way to kick off December, don't you know? Where are all the bloody naysayers today? We're raising a lot of money for charity! GLTA

Novocure plans to file for regulatory approval in the U.S., EU, Japan and other key markets; Zai Lab plans to file for regulatory approval in China https://www.businesswire.com/news/home/20241202363277/en/Zai-Lab-and-Novocure-Announce-Positive-Topline-Results-from-Phase-3-PANOVA-3-Clinical-Trial-of-Tumor-Treating-Fields-TTFields-Therapy-for-Pancreatic-Cancer

Looking good $30 +
50% 
12:09 PM EST, 12/02/2024 (MT Newswires) -- (Updates with stock move in the headline and first paragraph.)NovoCure's (NVCR) shares rose more than 41% in recent Monday trading after the company and Zai Lab (ZLAB) said that their phase 3 trial evaluating TTFields along with gemcitabine and nab-paclitaxel as a treatment for unresectable, locally advanced pancreatic adenocarcinoma achieved its primary endpoint, demonstrating a "statistically significant" improvement in median overall survival.NovoCure (NVCR) plans regulatory filings in the US, EU, Japan, and other major markets, while Zai Lab plans to file for regulatory approval in China, the companies said.

would love to see new session high
data is hot --- Can become SOC

$NVCR back above $20! GLTA

NVCR: One has to be patently BRAIN DEAD to attribute any significance whatsoever to the 1890's-like ELECTRICAL, cure-all, gadgets that this obvious SCAM company promotes!!!

FDA Approves Novocure’s Optune Lua for the Treatment of Metastatic Non-Small Cell Lung Cancer https://www.businesswire.com/news/home/20241015381082/en

Lovely action AH $NVCR! I can't wait for the opening bell, wishing everyone a great evening! GLTA

$NVCR great way to end the trading day! GLTA

I own both $NVCR and $NWBO, all proceeds will go to charity. GLTA

Glad to see you are in the right stock, NWBO, now!!

Who is the bag holder now???

Going to single digits

Come fly with me, let's fly let's fly away! Ol blue eyes, what a beautiful voice! Great start $NVCR! GLTA

Back above $20 $NVCR! GLTA

Another week, another beautiful day for $NVCR shareholders! GLTA

Another beautiful start of the week for $NVCR! GLTA

LOL - Go from over $200 to $20.
Wondering why this charity worker is NWBO hater.
Wondering why a self proclaimed good spirit tries so hard to destroy a great cancer therapy company. NWBO, hat is not NVCR??
A true charity worker expected to be compassionate, caring, and greatful of all possible potentials...

BUT not this guy??

You judge!!!

KARMA!!

GO $NVCR GO! We're making A LOT of $$$$$ for charities don't you know? GLTA

Beautiful day $NVCR! GLTA

It's been another great week for $NVCR! Have a wonderful weekend everyone! GLTA

Insiders to sell shares in 30 days

LOL 🤣🤣🤣

Or you can simply wait.

Well that's fantastic mate! Perhaps I'll have my lawyer contact her, have a great weekend! GLTA

By now, you should be smart enough to know that Laura Posner or Elliott Leary would be able to get IP address of each poster on NWBO board.

libel? Which part is libel? Nemesis18's post style is very similar to yours, would you agree?

No, do you? GLTA

I'd be careful you're getting a wee bit close to libel don't you know? GLTA

Great way to end the week! Finish strong $NVCR! Have a great weekend everyone! GLTA

You're posting on the wrong board mate, $NWBO is the one dealing with toxic financers go over there and post your rubbish! GLTA

Streeterville Capital, LLC is a Chicago-based company owned by John M. Fife, who has been described as a "toxic lender" for many years. Toxic financing is a type of financing that companies use when they are in poor condition and can't get financing in any other way. It can come in the form of convertible debt or convertible preferred stock and often gives the debtholder an unlimited number of common shares when they convert their debt or preferred shares to common stock.

Toxic financing for a company who’s price is down 90% in last 3 years

Today is the pump. Tomorrow is the insider dump

What a great day right Nemeses 18?
How is dat charity holding da bag???

Gone with the wind on wings of fake therapy IMO

20? including a PRE-CLINICAL???? lol
And all that unfocused activity signal the total desperation to keep the SP up IMO...

Reminds me of INO, which also kept throwing stuff at every possible thing, hoping one would stick.... But NO... INO SP at one time was over $2000 & now is around $11 after a recent RS

Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024

https://www.biospace.com/article/releases/novocure-announces-20-presentations-on-tumor-treating-fields-highlighting-preclinical-effects-in-pancreatic-cancer-and-immune-effects-at-american-association-for-cancer-research-aacr-annual-meeting-2024/

#dcvax $nwbo #gbm

Washinton State's HCA has denied coverage for Tumor Treating Fields, preventing access to this treatment option for Washington Medicaid patients and state employees.

'Optune/Tumor Treating Fields (TTF):
Petition for rereview received. Not selected for… pic.twitter.com/OPPsTyjXhk— Peter Davis (@peter_brit) April 2, 2024

This ship is sinking fast!